Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With Cat Dander

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2019

Primary Completion Date

February 9, 2023

Study Completion Date

February 9, 2023

Conditions

Rhinoconjunctivitis With or Without Allergic Asthma

Interventions

BIOLOGICAL

Beltavac® Polymerized with cat dander

Adminstration of Beltavac® Polymerized with cat dander according to the routine clinical practice

Trial Locations (7)

Campus de la Salud University Hospital, Granada

Ciudad de Jaen Hospital, Jaén

Quirón Campo de Gibraltar Hospital, Palmones

Quirón Malaga Hospital, Málaga

Al-lergo Centre Clinic, Barcelona

Bellvitge University Hospital, Barcelona

Alergogranada, Granada

All Listed Sponsors

lead

Probelte Pharma S.L.U.

INDUSTRY

NCT04207697 - Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With Cat Dander | Biotech Hunter | Biotech Hunter